Asia-Pacific Anticoccidial Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Asia-Pacific Anticoccidial Drugs Market is segmented by Drug Type (Ionophore Anticoccidials and Chemical Derivative Anticoccidials), Animal, and Geography.

Market Snapshot

Market Snapshot1
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 4.4 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Asia-Pacific Anticoccidial Drugs Market is expected to register a CAGR of 4.4% during the forecast period. Coccidiosis is a parasitic infection of the intestinal tract of animals which is caused by coccidian protozoa. The disease spreads from one animal to another by means of infected faeces or ingestion of infected tissue. To overcome this condition, anticoccidial drugs play a key role in the treatment and prevention of coccidiosis.

As per the study report in Science daily 2019, stated that since 2000, meat production has increased by more than 60% in Africa and Asia, and by 40% in South America, as countries shifted from low- to high-protein diets thus, driving the growth of the market. More than half of the world's chickens and pigs are in Asia.

The major factors driving the growth of the market in the Asia region is due to the rising incidence of coccidiosis in food-producing animals and companion animals, increased demand for meat proteins in countries like China, India, Malaysia, etc.

However, the use of alternative treatments, such as vaccines and herbal remedies, to treat Coccidiosis is likely to hamper the growth of the anticoccidial drugs market.

Scope of the report

Coccidiosis is one of the most frequent and prevalent parasitic diseases among domesticated animals and its symptoms include weight loss, mild intermittent to severe diarrhea, feces containing mucus or blood, dehydration, and decreased breeding. Any drug used to combat the progression of coccidiosis in birds or animals, both food-producing and non-food producing, is termed as an anticoccidial. The Asia-Pacific Anticoccidial Drugs Market is segmented by drug type, animal, and geography.

By Drug Type
Ionophore Anticoccidials
Chemical Derivative Anticoccidials
By Animal
Companion Animals
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

Key Market Trends

Ionophore Anticoccidial Segment is Expected to dominate the Anticoccidial Drugs Market Over The Forecast Period

These drugs are widely used for the prevention of coccidiosis, due to its broad-spectrum activity against the majority of pathogenic species of coccidian and lack of development of drug resistance. Each has a different mode of action and no significant resistance has been developed. These drugs are commonly added to the starter and grower feeds, but not to the finisher or withdrawal feeds.

For many years, ionophores have been the choice to control coccidiosis because resistance develops slowly because they do not completely suppress parasite development, thus allowing the development of immunity in the host after first exposure.

In Australia, Elanco offers "Maxiban" is a unique combination product for coccidiosis prevention in broilers. Thus, owing to the above factors the segment is expected to grow over the forecast period.

APAC Anticoccidial key trend 1.png

Competitive Landscape

The Asia-Pacific Anticoccidial Market is competitive. Major market players are primarily focusing on continuous product development, while adopting growth strategies, such as mergers, acquisitions, and partnerships with other market players. Major players include Bayer Animal Healthcare, Boehringer Ingelheim, Elanco Animal Health, Merck, Virbac, and Zoetis Animal Healthcare, among others.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence of Coccidiosis

      2. 4.2.2 Advancements in Veterinary Healthcare

    3. 4.3 Market Restraints

      1. 4.3.1 Availability of Alternative Treatment Options in the Market

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Drug Type

      1. 5.1.1 Ionophore Anticoccidials

      2. 5.1.2 Chemical Derivative Anticoccidials

    2. 5.2 By Animal

      1. 5.2.1 Poultry

      2. 5.2.2 Swine

      3. 5.2.3 Fish

      4. 5.2.4 Cattle

      5. 5.2.5 Companion Animals

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific


    1. 6.1 Company Profiles

      1. 6.1.1 Elanco

      2. 6.1.2 Vetoquinol SA

      3. 6.1.3 Huvepharma

      4. 6.1.4 Virbac

      5. 6.1.5 Zoetis Animal Healthcare

      6. 6.1.6 MSD Animal Health

      7. 6.1.7 Boehringer Ingelheim International GmbH

      8. 6.1.8 Ceva Animal Health Inc

      9. 6.1.9 Bayer AG

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Anticoccidial Drugs Market market is studied from 2018 - 2026.

The Asia-Pacific Anticoccidial Drugs Market is growing at a CAGR of 4.4% over the next 5 years.

Elanco, Vetoquinol SA, Huvepharma, Virbac, Zoetis Animal Healthcare are the major companies operating in Asia-Pacific Anticoccidial Drugs Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!